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Importance of identifying factors that limit 
participation in genetic studies
For  studies  involving  human  research  subjects  it  is,  in 
general, crucial to keep up participation rates in order to 
reduce  the  risk  of  sample  bias,  that  is,  the  systematic 
under-representation  of  certain  groups  in  the  study 
sample, which can potentially bias the research results. 
So far, genetic research has often faced greater difficulties 
than  non-genetic  research  in  recruiting  participants, 
although participation rates can vary widely [1]. Recent 
discussions suggest that research subjects can experience 
‘research  fatigue’  after  being  over-researched,  making 
them  less  prone  to  consent  to  further  participation, 
indicating that there might be increasing difficulties in 
recruiting subjects in the future. This could be especially 
problematic for genetic studies that are added on to a 
plethora  of  existing  non-genetic  studies.  In  order  to 
reduce non-participation, which may be due to a variety 
of factors, it is crucial for researchers to find out why 
different patient groups, and healthy individuals, choose 
not to participate in genetic research. While some factors 
may be strongly tied to specific patient categories, others 
may be of more general relevance [1].
A study by Lanfear and colleagues [1], published in this 
issue of Genome Medicine, addresses this important issue 
by  examining  a  large  number  of  factors  potentially 
influencing  recruitment  to  a  genetic  study  of  patients 
with myocardial infarction (MI). This work fills a gap in 
the literature regarding participation in genetic research 
among  patients  with  acute  illnesses,  but  the  results  of 
Lanfear  and  colleagues  are  also  of  general  interest  to 
anyone doing genetic research involving patient material. 
They  identify  one  factor,  the  site  of  enrollment,  as 
particularly important for successful recruitment, while 
their  results  indicate  that  most  others  are  of  limited 
relevance.
Significance of the enrollment site
Taking TRIUMPH (Translational Research Investigating 
Underlying disparities in recovery from acute Myocardial 
infarction: Patients’ Health status), a prospective multi-
center registry of patients with MI, as their starting point, 
Lanfear et al. examined factors associated with partici  pa-
tion or non-participation of registered patients with MI 
in a genetic sub-study [1]. Data for all patients included 
in  the  study,  enrolled  in  the  24  hospitals  involved  in 
TRIUMPH, were collected. Using trained data collectors 
at each site, a broad spectrum of information was ob-
tained, including data on health status, medical history, 
sociodemographic data, socioeconomic status and social 
support.  Standardized  sets  of  questions  were  used  to 
quantify  psychosocial  and  health  status  charac  teristics 
for each patient.
The overall consent rate to donate genetic material as 
part of the TRIUMPH sub-study was 80%, but Lanfear et 
al. observed considerable variations between the different 
enrollment sites. Rates of consent ranged from 100% of 
the  patients  enrolled  in  TRIUMPH  to  as  low  as  40%, 
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where the patients with MI were asked to participate in 
the genetic study was the major identified dividing line 
between  participants  and  non-participants.  Only  two 
patient-level factors (race and body mass index (BMI)) 
showed statistically significant associations with rates of 
participation. More specifically, African-American patients 
showed a lower participation rate compared with white 
patients, a result that is in line with previous experiences 
from  studies  in  the  USA  [2-4].  Lanfear  and  colleagues 
take this factor to be of real practical significance and 
stress  the  importance  of  being  aware  of  it  in  order  to 
counter the risk that African Americans are under-repre-
sented in genetic studies. Patients with a BMI ≥25 were 
associated with a slightly higher participation rate, com-
pared with the others included in the study. Noting that 
such an association has not previously been reported and 
seems difficult to explain, Lanfear et al. are inclined to 
interpret this finding as of questionable clinical importance.
Other  factors,  such  as  education  and  gender  [3,5], 
which have been identified as relevant for participation in 
genetic research in other studies, were not found to be 
significant. In contrast to the results and interpretations 
presented  in  the  article  by  Lanfear  and  colleagues, 
personal demographics, health status and sociocultural 
dimensions are frequently claimed to influence partici-
pation in research. These assumptions are supported by a 
number of studies, although other studies point in the 
opposite direction [3,6]. The role of enrollment sites is 
usually  not  discussed  as  such,  but  factors  tied  to  the 
enrollment situation, such as information provided and 
communication  style,  occur  in  discussions  of  factors 
affecting participation rates [3,4,7,8].
Potential for improvement
The results obtained by Lanfear and his colleagues might 
be  viewed  with  optimism.  Although  the  underlying 
mechanisms affecting participation rates at the different 
enrollment centers are not explained in this study, the 
authors find it likely that differences in recruitment rates 
depend  on  differences  in  the  individual  study  coordi-
nators’ motivation to recruit, presentation style, ability to 
provide patients with satisfactory information, and ability 
to establish a trusting relationship. If these assumptions 
are  correct,  for  which  there  is  some  support  in  the 
literature [4,7,8], then there may be considerable poten-
tial for improving participation rates by better training 
and  standardization  of  enrollment  processes.  In  turn, 
high-quality enrollment processes could potentially lead 
to improved quality in genetic association studies.
This view is shared by others who report good recruit-
ment  results  after  having  refined  their  recruitment 
practices  [3,4,7,8].  Open,  frequent  and  personalized 
communication  with  potential  participants  has  been 
identified as one potential success factor [3,7,8]. Reducing 
a  perceived  cultural  gap  and  an  accompanying  lack  of 
trust by, for instance, hiring an African-American nurse 
to  increase  recruitment  among  African  Americans  is 
another [7]. Reducing mental and practical barriers by 
combining  recruitment  with  educational  sessions  or 
enrolling at locations closer to underrepresented groups 
has also appeared to be fruitful, as has the use of targeted 
recruitment material and engagement of the concerned 
patient group in discussions on the ethical aspects of the 
study [4,6,7]. For long-term studies, the importance of 
participant  involvement,  keeping  participants  updated 
and reliable routines for feeding back clinically relevant 
results obtained through genetic tests has been stressed 
[4,8].  However,  more  systematic  research  regarding 
potential  ‘success  factors’  is  needed.  How  to  optimize 
communication with potential participants and establish 
trust might be the core themes to focus on, as suggested 
by Lanfear et al.
Optimal or ethical recruitment - or both?
Success in recruiting participants may, in principle, come 
at  the  price  of  side-stepping  ethical  requirements  for 
research  involving  human  subjects,  such  as  providing 
appropriate  information  about  relevant  aspects  of 
participation.  This  means  that  proven  success  in 
recruiting  patients  to  genetic  studies  does  not  auto-
matically  imply  that  the  recruitment  process  is  to  be 
recommended. Enrollment centers may at times priori-
tize satisfying the urge of researchers for a large amount 
of  patient  material  over  concern  for  patient  autonomy 
and privacy. If trust relationships are to be main  tained, 
which seems necessary for success in recruit  ment in the 
long run [8], disregarding patient interests would be the 
wrong  way  to  proceed.  The  concerns  and  worries  of 
actual and potential research subjects need to be dealt 
with  thoughtfully.  Confidentiality  and  proper  data 
protection,  and  respect  for  privacy  and  autonomy,  are 
themes  that  have  been  pointed  out  as  particularly 
important by participants in genetic research [9,10].
Lanfear  et  al.  touch  upon  ethical  issues  in  the 
discussion  of  their  article,  where  they  underline  the 
importance of close collaboration between researchers, 
coordinators  and  institutional  review  boards,  among 
others, in order to guarantee that the interests of research 
subjects are well protected. Indeed, an underlying idea, 
shared by others [3,8], seems to be that good research 
ethics, in the sense of proper and respectful protection of 
the interests of actual and potential research subjects, is 
conducive to successful recruitment and thereby to high 
research quality.
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